×
Stock Screener
Stock Research
Top Dividend Stocks
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
MiNK Therapeutics Financial Statements 2019-2025 | INKT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Income Statement
Balance Sheet
Cash Flow Statement
Key Financial Ratios
Format: Annual
Format: Quarterly
Format: Annual
View Annual Reports
Loading...
Annual Data | Millions of US $ except per share data
2024-12-31
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Revenue
-
-
-
-
-
$0.69
Cost Of Goods Sold
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
$0.69
Research And Development Expenses
$6.336
$15.49
$23.115
$13.966
$9.509
$19.654
SG&A Expenses
$4.314
$7.431
$7.834
$4.64
$1.288
$3.828
Other Operating Income Or Expenses
$0.638
-
-
$-9.752
$-3.841
$0.508
Operating Expenses
-
-
-
-
-
-
Operating Income
$-10.012
$-22.921
$-30.949
$-28.359
$-14.637
$-22.285
Total Non-Operating Income/Expense
$0.504
$0.463
$2.958
$-1.854
$-1.602
$-1.518
Pre-Tax Income
$-9.509
$-22.458
$-27.991
$-30.213
$-16.239
$-23.802
Income Taxes
-
-
-
-
-
-
Income After Taxes
$-9.509
$-22.458
$-27.991
$-30.213
$-16.239
$-23.802
Other Income
-
-
-
-
-
-
Income From Continuous Operations
$-9.509
$-22.458
$-27.991
$-30.213
$-16.239
$-23.802
Income From Discontinued Operations
-
-
-
-
-
-
Net Income
$-10.785
$-22.458
$-27.991
$-30.213
$-16.239
$-23.802
EBITDA
$-9.797
$-22.717
$-30.828
$-28.281
$-14.582
$-22.248
EBIT
$-10.012
$-22.921
$-30.949
$-28.359
$-14.637
$-22.285
Basic Shares Outstanding
4
3
3
3
2
2
Shares Outstanding
4
3
3
3
2
2
Basic EPS
$-2.86
$-6.54
$-8.30
$-11.60
$-6.70
$-9.90
EPS - Earnings Per Share
$-2.86
$-6.54
$-8.30
$-11.60
$-6.70
$-9.90
www.jqwidgets.com